{"id":"https://genegraph.clinicalgenome.org/r/112d4b10-61cd-479e-a7a0-f3bea4c1b6a1v1.0","type":"EvidenceStrengthAssertion","dc:description":"*SLC41A1* was first reported in relation to an autosomal recessive kidney disease in 2013 (Hurd et al., PMID: 23661805). *SLC41A1* was associated with a kidney disease phenotype clinically, sonographically and histologically compatible with infantile nephronophthisis. In addition, respiratory symptoms and bronchiectasis have been reported in the 2 patients. At the time of this curation, there were no other single-gene disorders associated with this gene (other than ?Nephronophthisis-like nephropathy 2 (OMIM:619468)). Therefore, this assessment is based on this disease entity only and has been curated for *SLC41A1*-kidney disorder (MONDO:0005240). Only 1 single nucleotide variant that has been reported in homozygosity in 2 affected individuals from 1 consanguineous family in 1 publication (PMID: 23661805) is included in this curation. This acceptor splice site variant (c.698G>T) in *SLC41A1* has been shown to lead to skipping of exon 6 and an in-frame deletion of a transmembrane helix, with reduced protein expression and functional consequences. No other patients affected with *SLC41A1*-kidney disorder have been reported since 2013. The mechanism of pathogenicity is unknown as there is no described link between the function of SLC41A1 (magnesium transport) and the development of nephronophthisis. This gene-disease association is supported by limited experimental evidence including human kidney expression data and a morpholino-induced knockdown zebrafish model presenting with features compatible with a primary ciliopathy (PMID: 23661805). Of note, another study investigating morpholino-induced knockdown of *slc41a1* in zebrafish did not replicate the phenotypic features (PMID: 30417250). It is also noteworthy, that the 2 patients described with biallelic *SLC41A1* variants did not present with altered magnesium homeostasis and that a first cousin shared some clinical features (bronchiectasis) but was heterozygous for the family mutation (PMID: 23661805). In summary, there is limited evidence to support this gene-disease relationship that has not been replicated since 2013. Although more evidence is needed to support a causal role, no convincing human evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date 05/11/22 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/112d4b10-61cd-479e-a7a0-f3bea4c1b6a1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2022-09-19T12:32:28.948Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2022-05-11T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19173698-d389-4cd5-8c2d-395de2cd0e54","type":"EvidenceLine","dc:description":"Only 1 morpholino shown. \nContradictory evidence exists in literature (PMID: 30417250) where morpholino-induced knockdown of functional SLC41A1 causes renal Mg(2+) wasting in zebrafish and results in Mg(2+) deficiency but\ndid not lead to abnormal zebrafish embryo morphology neither to signs of renal cysts or tubular dilatations (120 hpf).  ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a8bd3bf-6a42-4de0-b31f-338d2dd8af25","type":"Finding","dc:description":"Phenotype observed in zebrafish is frequently observed upon knockdown of bona fide nephronophthisis-associated genes and associates SLC41A1 knockdown in zf with ciliopathy features. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661805","rdfs:label":"splice-blocking ASO zf shows ciliopathy features","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55c6ca80-93ed-4f5a-9b81-b6dfd2b04b15","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e701717-8ae6-4412-b221-5416235b7f7e","type":"Finding","dc:description":"Immunohistochemical analysis of SLC41A1 expression on normal human kidney sections revealed expression primarily in the distal convoluted tubules (DCTs) and in the tubule adjacent to the macula densa. Claudin16 was coexpressed in identical tubular segments to SLC41A1 in rat kidney sections. RT-PCR confirmed that SLC41A1 is expressed in the DCT and thick ascending limb but is absent from proximal convoluted tubule and cortical collecting duct of human microdissected tubular segments. These data reveal that SLC41A1 is expressed in the DCT, macula densa, and thick ascending limb tubular segments, whose location is entirely consistent with the region of cystogenesis observed in NPHP and related ciliopathies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661805","rdfs:label":"distal tubular expression in human kidney","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9eecff4-ba1a-4f7c-939b-deea55288e27_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ec0e4ef-048e-4950-ac60-3e490b03dfbd","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ec0e4ef-048e-4950-ac60-3e490b03dfbd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"SLC41A1 c.698G>T results in skipping of exon 6 ((EBV)â€“transformed white blood cells), predicted to result in an in-frame deletion of a transmembrane domain. Western blotting of protein lysates generated from both parental and patient derived cell lines revealed almost complete loss of SLC41A1 expression in the two affected siblings. Transfection of the WT and mutant constructs into the MDCKII renal epithelial cell line revealed that both targeted to the basolateral membrane and that the mutant localization was indistinguishable from WT (confirmed by cell-surface biotinylation\nassay). Furthermore, deletion of SLC41A1 exon 6 results in loss of Magnesium transport activity of SLC41A1.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0ec0e4ef-048e-4950-ac60-3e490b03dfbd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661805","allele":{"id":"https://genegraph.clinicalgenome.org/r/a94ae95f-4a3c-49a3-80ff-47560328a2c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_173854.6(SLC41A1):c.698G>T (p.Gly233Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1192530"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/f9eecff4-ba1a-4f7c-939b-deea55288e27","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661805","rdfs:label":"IV2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a94ae95f-4a3c-49a3-80ff-47560328a2c8"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0ec0e4ef-048e-4950-ac60-3e490b03dfbd_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/a1a853a0-854a-4b61-8b12-eaf8edeabee7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/408fd4f9-bf46-402c-b0a9-85a1bbe8522d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661805","rdfs:label":"F438","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/408fd4f9-bf46-402c-b0a9-85a1bbe8522d","type":"Family","rdfs:label":"F438","member":{"id":"https://genegraph.clinicalgenome.org/r/f9eecff4-ba1a-4f7c-939b-deea55288e27"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000090","obo:HP_0002110"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f9eecff4-ba1a-4f7c-939b-deea55288e27"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":5009,"specifiedBy":"GeneValidityCriteria8","strengthScore":4.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/d1MmW-QiBxY","type":"GeneValidityProposition","disease":"obo:MONDO_0005240","gene":"hgnc:19429","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a1a853a0-854a-4b61-8b12-eaf8edeabee7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}